Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1999 1
2002 1
2006 2
2007 1
2010 1
2011 2
2012 1
2013 1
2015 1
2016 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
[Polycystic ovary syndrome].
Vrbíková J. Vrbíková J. Vnitr Lek. 2015 Oct;61(10):886-95. Vnitr Lek. 2015. PMID: 26486483 Review. Czech.
It is not a gynecological disorder alone, the syndrome is accompanied by insulin resistance which leads to increased incidence of type 2 diabetes mellitus and impaired glucose tolerance (4 times and twice, independently of BMI). ...More often th …
It is not a gynecological disorder alone, the syndrome is accompanied by insulin resistance which leads to increased incidence of …
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.
Kirlangic OF, Yilmaz-Oral D, Kaya-Sezginer E, Toktanis G, Tezgelen AS, Sen E, Khanam A, Oztekin CV, Gur S. Kirlangic OF, et al. Sex Med. 2020 Jun;8(2):132-155. doi: 10.1016/j.esxm.2020.02.006. Epub 2020 Mar 20. Sex Med. 2020. PMID: 32201216 Free PMC article. Review.
INTRODUCTION: Cardiometabolic syndrome (CMS), as a bunch of metabolic disorders mainly characterized by type 2 diabetes mellitus (T2DM), hypertension, atherosclerosis, central adiposity, and abdominal obesity triggering androgen deficiency, is o …
INTRODUCTION: Cardiometabolic syndrome (CMS), as a bunch of metabolic disorders mainly characterized by type 2 diabetes …
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.
Barrett-Connor E. Barrett-Connor E. Ann Intern Med. 1992 Nov 15;117(10):807-11. doi: 10.7326/0003-4819-117-10-807. Ann Intern Med. 1992. PMID: 1416554
PARTICIPANTS: Men 53 to 88 years of age from the Rancho Bernardo, California, cohort who were screened for diabetes using an oral glucose tolerance test. MEASUREMENTS: Plasma androgen levels were compared in 44 men with untreated non-insulin- …
PARTICIPANTS: Men 53 to 88 years of age from the Rancho Bernardo, California, cohort who were screened for diabetes using an oral glu …
Sex steroids and insulin resistance.
Livingstone C, Collison M. Livingstone C, et al. Clin Sci (Lond). 2002 Feb;102(2):151-66. doi: 10.1042/cs1020151. Clin Sci (Lond). 2002. PMID: 11834135 Review.
Hyperinsulinaemia in patients with this condition is believed to stimulate ovarian androgen production, and there is also evidence that androgens act directly on peripheral tissues to promote insulin resistance. ...Recognition and treatment of sex steroid-ass …
Hyperinsulinaemia in patients with this condition is believed to stimulate ovarian androgen production, and there is also evidence th …
A study of hormonal and anthropometric parameters in polycystic ovarian syndrome.
Kambale T, Sawaimul KD, Prakash S. Kambale T, et al. Ann Afr Med. 2023 Jan-Mar;22(1):112-116. doi: 10.4103/aam.aam_15_22. Ann Afr Med. 2023. PMID: 36695232 Free PMC article.
PCOS is also showing an increased prevalence of several other conditions such as obesity, dyslipidemia, hypertension, metabolic syndrome and type 2 diabetes mellitus (DM2) when compared with women without PCOS. ...PCOS has metabolic characterist …
PCOS is also showing an increased prevalence of several other conditions such as obesity, dyslipidemia, hypertension, metabolic syndr …
Evaluation of metabolic parameters and aortic elasticity in normotensive children with premature adrenarche.
Topaktaş E, Erolu E, Dursun F, Kırmızıbekmez H. Topaktaş E, et al. J Pediatr Endocrinol Metab. 2021 Jun 24;34(8):1009-1015. doi: 10.1515/jpem-2021-0160. Print 2021 Aug 26. J Pediatr Endocrinol Metab. 2021. PMID: 34167179
OBJECTIVES: Premature adrenarche may be associated with an intrauterine programmed metabolic syndrome which should be considered as a warning sign for coronary heart disease due to accelerated atherosclerosis, hypertension, type 2 diabetes mellitus (DM …
OBJECTIVES: Premature adrenarche may be associated with an intrauterine programmed metabolic syndrome which should be considered as a warnin …
Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche.
Ibáñez L, Castell C, Tresserras R, Potau N. Ibáñez L, et al. Clin Endocrinol (Oxf). 1999 Oct;51(4):395-401. doi: 10.1046/j.1365-2265.1999.00778.x. Clin Endocrinol (Oxf). 1999. PMID: 10583304
Serum lipids and lipoproteins were measured in baseline blood samples in all subjects, while serum testosterone, sex hormone-binding globulin (SHBG) levels and the free androgen indices were determined only in females. Impaired glucose tolerance (IGT) and type …
Serum lipids and lipoproteins were measured in baseline blood samples in all subjects, while serum testosterone, sex hormone-binding …
The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study.
Zhang Z, Chen C, Wang Y, Wang N, Chen Y, Lu Y, Xia F. Zhang Z, et al. Eur J Med Res. 2022 Dec 27;27(1):307. doi: 10.1186/s40001-022-00958-8. Eur J Med Res. 2022. PMID: 36572925 Free PMC article.
BACKGROUND: Testosterone has an impact on metabolic disorders and men with type 2 diabetes mellitus (T2DM) are predisposed to hypogonadism; meanwhile, patients with T2DM have higher risk of NAFLD. ...Multinomial logistic regression and ordinal logistic …
BACKGROUND: Testosterone has an impact on metabolic disorders and men with type 2 diabetes mellitus (T2DM) are p …
Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA, Bothra N, Acharya SV, Ganesh HK, Bandgar TR, Menon PS, Shah NS. Gopal RA, et al. Endocr Pract. 2010 Jul-Aug;16(4):570-6. doi: 10.4158/EP09355.OR. Endocr Pract. 2010. PMID: 20150021 Clinical Trial.
OBJECTIVE: To investigate the effect of testosterone treatment on insulin resistance, glycemic control, and dyslipidemia in Asian Indian men with type 2 diabetes mellitus (T2DM) and hypogonadism. ...RESULTS: Treatment with testosterone di …
OBJECTIVE: To investigate the effect of testosterone treatment on insulin resistance, glycemic control, and dyslipidemia in As …
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
Kapoor D, Goodwin E, Channer KS, Jones TH. Kapoor D, et al. Eur J Endocrinol. 2006 Jun;154(6):899-906. doi: 10.1530/eje.1.02166. Eur J Endocrinol. 2006. PMID: 16728551 Clinical Trial.
We investigated the effect of testosterone treatment on insulin resistance and glycaemic control in hypogonadal men with type 2 diabetes. ...The primary outcomes were changes in fasting insulin sensitivity (as measured by homeostatic model index (HOMA) …
We investigated the effect of testosterone treatment on insulin resistance and glycaemic control in hypogonadal men with type 2 di …
17 results